Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have a scenario
Your absolutely right. Anyone taking possession of the MMP portfolio would still be faced with enforcement. You think companies are going to voluntarly step forward and admit infringing. If a company were interested in purchasing the patents it would still take an enormous amount of resources to enforce them. Alliacense is in the business of managing IP licensing. They have the infrastructure and expertise to extract the most value. I believe we are a long way from being in a position to sell the portfolio. IMO.
Share
New Message
Please login to post a reply